ABVL
Arunjyoti Bio Ventures financials
- Market cap
- ₹112 Cr
Quarterly results
Q1 FY27: revenue down 5.9%, net profit down 70.2% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6 | 6 | 5 | 9 | 5 −16% | 6 +5% | 7 +37% | 8 −6% |
| EBITDA | 1 | 0 | 0 | 4 | 0 −67% | 1 +318% | -2 −797% | 2 −42% |
| Net profit | -0 | -1 | -2 | 2 | -1 −459% | 0 +106% | -5 −171% | 1 −70% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −40.3% 1Y
1Y: ₹7.62 on 10 Sept 2025 → ₹4.55. High ₹12.71 (24 Oct 2025), low ₹4.55 (11 Sept 2026).
Financials, as filed
Revenue grew 301.2% a year over 3 years, FY10 to FY26. Operating margin widened to 10.5%.
| Year ending | FY10 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹20 Cr | ₹28 Cr | ₹28 Cr |
| Operating profit | ₹-0 Cr | ₹3 Cr | ₹5 Cr | ₹3 Cr |
| Operating margin | -16.3% | 13.6% | 17.9% | 10.5% |
| Interest | ₹0 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr |
| Depreciation | ₹0 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr |
| Net profit | ₹-0 Cr | ₹-0 Cr | ₹-1 Cr | ₹-5 Cr |
| Net margin | -23.3% | -1.7% | -5.1% | -16.3% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Who owns it
As disclosed at Jun 2026
The ownership split has held steady since Jun 2025. The shareholder count grew 277% to 20,483.
- Promoters
- 47.6%
- Public
- 52.4%
Since Jun 2025
- Public +0.01 pp
- Promoters 0.00 pp
How it drifted, 12 quarters
Over this window the public went from 51.0% to 52.4% — +1.3 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 49.0%, Public 51.0%.Dec '23: Promoters 49.0%, Public 51.0%.Mar '24: Promoters 49.0%, Public 51.0%.Jun '24: Promoters 61.8%, Public 38.2%.Sep '24: Promoters 61.8%, Public 38.2%.Dec '24: Promoters 61.0%, Public 39.0%.Mar '25: Promoters 47.6%, Public 52.4%.Jun '25: Promoters 47.6%, Public 52.4%.Sep '25: Promoters 47.6%, Public 52.4%.Dec '25: Promoters 47.6%, Public 52.4%.Mar '26: Promoters 47.6%, Public 52.4%.Jun '26: Promoters 47.6%, Public 52.4%.
Who is on the register
Named in the Jun 2026 filing
Every holder of Arunjyoti Bio Ventures Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Dathvik Pabbathi | 23.07% | unchanged |
| Pabbathi Badari Narayana Murthy | 19.25% | unchanged |
| Ponnuru Siva Ratna Maha Lakshmi Prasanna | 5.31% | unchanged |
| Chennupati Sarath Kumar | 4.23% | −6.30 pp |
| Vanaja Veeramreddy | 3.73% | unchanged |
| Sreedar Reddy G | 3.12% | unchanged |
| Shashank Sai Pabbathi | 2.54% | unchanged |
| Sanivarapu Jhansi | 2.37% | unchanged |
| Sirisha Pabbathi | 2.06% | unchanged |
| Sandeep Kapadia | 1.93% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Arunjyoti Bio Ventures Limited
Guides on how to read this kind of business and the numbers that matter.